Alloantigen-specific regulatory T cells prevent experimental chronic graft-versus-host disease by simultaneous control of allo- and autoreactivity
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alloantigen-specific regulatory T cells prevent experimental chronic graft-versus-host disease by simultaneous control of allo- and autoreactivity
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 42, Issue 12, Pages 3322-3333
Publisher
Wiley
Online
2012-09-19
DOI
10.1002/eji.201242770
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CTL-Promoting Effects of CD40 Stimulation Outweigh B Cell-Stimulatory Effects Resulting in B Cell Elimination and Disease Improvement in a Murine Model of Lupus
- (2014) R. Puliaev et al. JOURNAL OF IMMUNOLOGY
- Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease
- (2012) H. Rangarajan et al. BLOOD
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- Graft-versus-host disease
- (2012) Sharon R. Hymes et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
- (2011) M. E. D. Flowers et al. BLOOD
- Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts
- (2011) C. G. Brunstein et al. BLOOD
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- Treatment of chronic graft-versus-host disease in 2011
- (2011) Yoshihiro Inamoto et al. CURRENT OPINION IN HEMATOLOGY
- Monitoring of In Vivo Function of Superparamagnetic Iron Oxide Labelled Murine Dendritic Cells during Anti-Tumour Vaccination
- (2011) Richard Tavaré et al. PLoS One
- Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells
- (2011) P. Sagoo et al. Science Translational Medicine
- The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient
- (2010) J. N. Beilke et al. BLOOD
- Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease
- (2010) Xiaofeng Qian et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
- (2009) S. Sarantopoulos et al. BLOOD
- Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
- (2009) A. C. Vigorito et al. BLOOD
- Indefinite mouse heart allograft survival in recipient treated with CD4+CD25+ regulatory T cells with indirect allospecificity and short term immunosuppression
- (2009) Julia Yuen-Shan Tsang et al. TRANSPLANT IMMUNOLOGY
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues
- (2008) Yu-Waye Chu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The importance of the indirect pathway of allorecognition in clinical transplantation
- (2008) M Refik Gökmen et al. CURRENT OPINION IN IMMUNOLOGY
- Regulatory T cells as therapeutic cells
- (2008) Pervinder Sagoo et al. Current Opinion in Organ Transplantation
- Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice
- (2008) Julia Yuen-Shan Tsang et al. JOURNAL OF CLINICAL INVESTIGATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started